Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
Newer and emerging therapies including plant derived compounds offer hope for an improved lifestyle and better chances for survival
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Heres a quick rundown on each medication: Wegovy Injectable medication that is self-administered once a week
FAD is important for producing energy both from carbohydrates and through fatty-acid oxidation in the mitochondria.[ref] FAD is also involved in detoxification as a cofactor for some CYP450 enzymes, as well as for glutathione recycling